55,498 Shares in Cigna Group $CI Purchased by Nykredit A S

Key Points

• Nykredit A/S acquired 55,498 shares of Cigna Group during the second quarter, valued at approximately $15.3 million. Institutional investors collectively own 86.99% of the company.
• Analysts maintain a generally positive view, with 15 Buy ratings and eight Hold ratings, producing a “Moderate Buy” consensus and an average price target of $337.10.
• Cigna exceeded quarterly earnings expectations with $7.78 in EPS versus $7.60 estimated, while revenue rose 6.7% year over year. The company also declared a quarterly dividend of $1.56 per share, yielding about 2.3% annually.

Nykredit A S bought a new position in shares of Cigna Group (NYSE:CI - Free Report) during the 2nd quarter, according to its most recent filing with the SEC. The institutional investor bought 55,498 shares of the health services provider's stock, valued at approximately $15,300,000.

Several other hedge funds have also recently modified their holdings of CI. Osbon Capital Management LLC bought a new stake in Cigna Group during the 2nd quarter valued at $26,000. Cedar Mountain Advisors LLC lifted its stake in shares of Cigna Group by 161.9% during the 1st quarter. Cedar Mountain Advisors LLC now owns 110 shares of the health services provider's stock worth $29,000 after purchasing an additional 68 shares during the last quarter. Johnson Financial Group Inc. purchased a new stake in shares of Cigna Group during the 2nd quarter worth $29,000. Fiduciary Financial Advisors bought a new stake in Cigna Group during the second quarter valued at about $29,000. Finally, ANTIPODES PARTNERS Ltd bought a new stake in Cigna Group during the second quarter valued at about $34,000. Hedge funds and other institutional investors own 86.99% of the company's stock.

Analysts Set New Price Targets

CI has been the subject of several analyst reports. Jefferies Financial Group lowered shares of Cigna Group from a "buy" rating to a "hold" rating and decreased their price target for the company from $336.00 to $307.00 in a research report on Tuesday, August 4th. Guggenheim boosted their price objective on shares of Cigna Group from $338.00 to $361.00 and gave the stock a "buy" rating in a research note on Friday, July 31st. Evercore initiated coverage on shares of Cigna Group in a research report on Wednesday, September 9th. They set an "in-line" rating and a $290.00 target price for the company. Robert W. Baird set a $362.00 target price on shares of Cigna Group in a research note on Friday, July 31st. Finally, Mizuho upped their price target on Cigna Group from $330.00 to $340.00 and gave the stock an "outperform" rating in a research report on Monday, June 8th. Fifteen equities research analysts have rated the stock with a Buy rating and eight have given a Hold rating to the company's stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $337.10.

Cigna Group Stock Performance

Shares of Cigna Group stock opened at $275.57 on Friday. The company has a 50 day moving average price of $282.67 and a 200 day moving average price of $280.67. The firm has a market capitalization of $72.82 billion, a P/E ratio of 11.40, a PEG ratio of 0.95 and a beta of 0.31. The company has a quick ratio of 0.76, a current ratio of 0.76 and a debt-to-equity ratio of 0.68. Cigna Group has a 52 week low of $239.51 and a 52 week high of $315.47.

Cigna Group (NYSE:CI - Get Free Report) last issued its quarterly earnings results on Thursday, July 30th. The health services provider reported $7.78 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $7.60 by $0.18. The business had revenue of $70.04 billion for the quarter, compared to analyst estimates of $70.14 billion. Cigna Group had a net margin of 2.27% and a return on equity of 19.75%. Cigna Group's revenue for the quarter was up 6.7% compared to the same quarter last year. During the same quarter in the prior year, the business posted $7.20 EPS. Cigna Group has set its FY 2026 guidance at 30.450- EPS. Sell-side analysts expect that Cigna Group will post 30.51 EPS for the current year.

Cigna Group Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, September 23rd. Shareholders of record on Tuesday, September 8th will be given a dividend of $1.56 per share. The ex-dividend date of this dividend is Tuesday, September 8th. This represents a $6.24 dividend on an annualized basis and a yield of 2.3%. Cigna Group's payout ratio is currently 25.82%.

Insider Transactions at Cigna Group

In other Cigna Group news, insider Everett Neville sold 617 shares of the business's stock in a transaction dated Thursday, September 3rd. The stock was sold at an average price of $284.05, for a total transaction of $175,258.85. Following the sale, the insider owned 5,053 shares in the company, valued at approximately $1,435,304.65. The trade was a 10.88% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Nicole Jones sold 2,677 shares of the stock in a transaction dated Tuesday, August 18th. The shares were sold at an average price of $279.61, for a total value of $748,515.97. Following the completion of the transaction, the insider directly owned 25,880 shares in the company, valued at $7,236,306.80. This represents a 9.37% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders have sold 22,730 shares of company stock valued at $6,293,359. 0.60% of the stock is currently owned by insiders.

Cigna Group Profile

The Cigna Group NYSE: CI is a global health services company that helps individuals, employers, health plans and government organizations access health care and related services. The company operates primarily through two businesses: Cigna Healthcare, which provides medical, behavioral health, dental and other health benefit products and services, and Evernorth Health Services, which offers pharmacy, care delivery and health benefits solutions.

Evernorth includes Express Scripts, a pharmacy benefit services provider that manages prescription drug benefits and operates home delivery and specialty pharmacy services.

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CI - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.